Naproxen/rizatriptan

N/A

Report date: 2025/12/18 17:47:06

Base Information

Drug NameNaproxen/rizatriptan

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionCyclooxygenases inhibitorsSerotonin 1d (5-HT1d) receptor agonistsSerotonin 1b (5-HT1b) receptor agonists

TargetsSerotonin 1d (5-HT1d) receptorCyclooxygenasesSerotonin 1b (5-HT1b) receptor

Therapy Area/IndicationsMigraine Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEurofarma

China Registration ClassN/A

Active CompaniesEurofarma

Inactive CompaniesN/A

Active IndicationsMigraine Disorders

Inactive IndicationsN/A

ATC CodeN/A